Derek J. Eberwein

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Nelson Rhodes, Dirk A. Heerding, Derek R. Duckett et al. · Cancer Research · 2008 · 298 citations · Full text

Medicine, Oncology, Pharmacology +17

Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors

Stephen T. Davis, Bill Benson, H. Neal Bramson et al. · Science · 2001 · 167 citations

Medicine, Oncology, Pharmacology +15

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

Dirk A. Heerding, Nelson Rhodes, Jack D. Leber et al. · Journal of Medicinal Chemistry · 2008 · 155 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Mechanism and Management of AKT Inhibitor-Induced Hyperglycemia

Ming‐Chih Crouthamel, Jason A. Kahana, Susan Korenchuk et al. · Clinical Cancer Research · 2008 · 123 citations

Medicine, Endocrinology, Pharmacology +17

Vinorelbine Tartrate and Paclitaxel Combinations: Enhanced Activity Against In Vivo P388 Murine Leukemia Cells

V C Knick, Derek J. Eberwein, Cathie G. Miller · JNCI Journal of the National Cancer Institute · 1995 · 70 citations

Medicine, Oncology, Pharmacology +15